Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (53)

2024

  1. Endocrine activity of dysfunctional adipose tissue: Cardiovascular risk and progression markers

    International Journal of Cardiology

  2. Semaglutide modulates prothrombotic and atherosclerotic mechanisms, associated with epicardial fat, neutrophils and endothelial cells network

    Cardiovascular Diabetology, Vol. 23, Núm. 1

2023

  1. Clinical Profiling and Biomarkers for Post-Operative Atrial Fibrillation Prediction in Patients Undergoing Cardiac Surgery

    Journal of Clinical Medicine, Vol. 12, Núm. 10

2022

  1. Diabesity in Elderly Cardiovascular Disease Patients: Mechanisms and Regulators

    International journal of molecular sciences, Vol. 23, Núm. 14

  2. Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers

    Scientific Reports, Vol. 12, Núm. 1

  3. Synergism between obesity and HFpEF on neutrophils phenotype and its regulation by adipose tissue-molecules and SGLT2i dapagliflozin

    Journal of Cellular and Molecular Medicine, Vol. 26, Núm. 16, pp. 4416-4427

  4. The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure

    Cells, Vol. 11, Núm. 8

  5. The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

2021

  1. A New Biomarker Tool for Risk Stratification in “de novo” Acute Heart Failure (OROME)

    Frontiers in Physiology, Vol. 12

  2. Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer

    European Journal of Clinical Investigation, Vol. 51, Núm. 5

  3. Sex-related differences of fatty acid-binding protein 4 and leptin levels in atrial fibrillation

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 23, Núm. 5, pp. 682-690

  4. Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value

    Journal of Molecular Medicine, Vol. 99, Núm. 12, pp. 1741-1753

  5. Updates on epicardial adipose tissue mechanisms on atrial fibrillation

    Obesity Reviews, Vol. 22, Núm. 9

2020

  1. CD5L, Macrophage Apoptosis Inhibitor, Was Identified in Epicardial Fat-Secretome and Regulated by Isoproterenol From Patients With Heart Failure

    Frontiers in Physiology, Vol. 11

  2. COVID-19 and treatment guided by biochemical and molecular diagnostic tests to reduce myocardial damage and cardiotoxicity

    Revista Espanola de Cardiologia

  3. High released lactate by epicardial fat from coronary artery disease patients is reduced by dapagliflozin treatment

    Atherosclerosis, Vol. 292, pp. 60-69

  4. Inflammatory and lipid regulation by cholinergic activity in epicardial stromal cells from patients who underwent open-heart surgery

    Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 18, pp. 10958-10969

  5. Myocardium metabolism in physiological and pathophysiological states: Implications of epicardial adipose tissue and potential therapeutic targets

    International Journal of Molecular Sciences, Vol. 21, Núm. 7

2019

  1. Cholinergic activity regulates the secretome of epicardial adipose tissue: Association with atrial fibrillation

    Journal of Cellular Physiology, Vol. 234, Núm. 7, pp. 10512-10522

  2. Long-Term Weight Gain Associated With High Omentin Levels at Hospital Discharge Improves Prognosis of Patients Following Acute Heart Failure

    Journal of Cardiovascular Translational Research, Vol. 12, Núm. 3, pp. 231-239